Gene · 11167
FSTL1: follistatin like 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FSTL1: follistatin like 1. Genes, record 11167. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/11167
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q12841 | Follistatin-related protein 1 | 308 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents67
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 46513 | Q12841 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3633 | Q12841 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 5575 | Q12841 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6424 | Q12841 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6424 | Q12841 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3633 | Q12841 | Espacenet |
| JP 2025065222 A | 2025-04-17 | 1 | Q12841 | Espacenet |
| JP 2025510782 A | 2025-04-15 | 1 | Q12841 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 5575 | Q12841 | Espacenet |
| EP 4499125 A1 | 2025-02-05 | 1 | Q12841 | Espacenet |
1 to 10 of 67
See all 67 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,048
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FSTL1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 3 | 2025 |
| P30CA023168 | Cancer Center Support Grant | 2 | 2025 |
| P30CA043703 | Case Comprehensive Cancer Center Support Grant | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| P30CA082709 | Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant | 2 | 2025 |
| P30DK020593 | Vanderbilt Diabetes Research Center | 2 | 2025 |
| P30DK056350 | Nutrition Obesity Research Center (NORC) | 2 | 2025 |
| P30ES006694 | Southwest Environmental Health Sciences Center | 2 | 2025 |
| P30ES009089 | Center for Environmental Health in Northern Manhattan | 2 | 2025 |
1 to 10 of 1,048Source NIH's project files
See all 1,048 nih grantsPapers1,795
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Changes in the concentration of new adipokines in serum and peritoneal fluid of patients with serous ovarian cancer as a target for potential use in new diagnostic and therapeutic strategies. | Ginekol Pol | 2026 | 42814914 | PubTator, text mining | PubMed |
| Targeting the CAF-LPL-STAT3 axis mitigates osimertinib resistance associated with EGFR downregulation. | Cell Signal | 2026 | 42810632 | PubTator, text mining | PubMed |
| Novel cardiac biomarkers (serum S100A12 (Calgranulin C), FSTL1 (Follistatin-like 1), and osteocalcin) in patients with acute chest pain. | J Med Biochem | 2026 | 42781349 | PubTator, text mining | PubMed |
| Secreted Frizzled-Related Protein 2 (SFRP2) Induces Follistatin-Like 1 (FSTL1) to Regulate Dihydrotestosterone (DHT)-Induced Dermal Papilla Cell Mitochondrial Dysfunction and Senescence. | Aging Cell | 2026 | 42698274 | PubTator, text mining | PubMed |
| One ligand, multiple fates: the multi-receptor signaling network of FSTL1 and receptor-selective intervention strategies. | Biochem Pharmacol | 2026 | 42667965 | PubTator, text mining | PubMed |
| Molecular Mechanisms Governing Vascular Function in Heart Failure. | Arterioscler Thromb Vasc Biol | 2026 | 42619591 | PubTator, text mining | PubMed |
| Exercise-induced Myokines and Muscle-Vascular Crosstalk in Peripheral Artery Disease Management: From Bench to Practice. | Int J Angiol | 2026 | 42559626 | PubTator, text mining | PubMed |
| Liver Endothelia Orchestrate MASH-Associated Macrophage Zonation Through FSTL1-ITGA4 Axis. | Adv Sci (Weinh) | 2026 | 42545862 | PubTator, text mining | PubMed |
| Signaling pathways regulating cardiac regeneration. | Cell Regen | 2026 | 42518135 | PubTator, text mining | PubMed |
| Neonatal CD19+B220lo cells sense microbiota via TLR2/4 activation driving proliferation and differentiation. | Front Immunol | 2026 | 42404882 | PubTator, text mining | PubMed |
1 to 10 of 1,795
See all 1,795 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/11167
GET https://conductscience.org/api/genes/v1/11167/patents?page=2